Advertisement
Screener

ACCURAY INCORPORATED (ARAY) Overview

ACCURAY INCORPORATED (ARAY) Overview

  • 1 Oct 2025: Period ending 31 Dec 2025; Estimate (m); Actual -0.11; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.18; Beat / miss (m).
  • 1 Jan 2025: Period ending 31 Mar 2025; Estimate (m); Actual -0.01; Beat / miss (m).
  • 1 Oct 2024: Period ending 31 Dec 2024; Estimate (m); Actual 0.02; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$0.21$0.33$0.51$0.80$1.24$1.942025-09-292026-09-29$0.21$0.41$0.81$1.59$3.14$6.172021-09-292026-09-29$0.21$0.42$0.84$1.67$3.34$6.692016-09-292026-09-29$0.21$0.57$1.54$4.17$11.32$30.712007-02-082026-09-29$0.21$0.57$1.54$4.17$11.32$30.712007-02-082026-09-29

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$0.30
Previous close
$0.30
Change
$0.00
Change (%)
0.00%
Close date
2026-09-29
Previous close date
2026-09-28
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

ARAY
-63.41%
S&P 500
(m)

1 year

ARAY
-81.60%
S&P 500
(m)

3 years

ARAY
-88.97%
S&P 500
(m)

5 years

ARAY
-92.44%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

31 Dec 2025 ○ Estimate (m) ● Actual -0.11

-0.26-0.15-0.030.080.2030 Sept 2024: estimate (m); actual -0.0430 Sept 2024(m)31 Dec 2024: estimate (m); actual 0.0231 Dec 2024(m)31 Mar 2025: estimate (m); actual -0.0131 Mar 2025(m)30 Sept 2025: estimate (m); actual -0.1830 Sept 2025(m)31 Dec 2025: estimate (m); actual -0.1131 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Oct 202531 Dec 2025(m)-0.11(m)(m)
1 Jul 202530 Sept 2025(m)-0.18(m)(m)
1 Jan 202531 Mar 2025(m)-0.01(m)(m)
1 Oct 202431 Dec 2024(m)0.02(m)(m)
1 Jul 202430 Sept 2024(m)-0.04(m)(m)

30 Jun 2025 ○ Estimate (m) ● Actual -0.02

-0.24-0.14-0.040.060.1630 Jun 2021: estimate (m); actual -0.0730 Jun 2021(m)30 Jun 2022: estimate (m); actual -0.0630 Jun 2022(m)30 Jun 2023: estimate (m); actual -0.1030 Jun 2023(m)30 Jun 2024: estimate (m); actual -0.1630 Jun 2024(m)30 Jun 2025: estimate (m); actual -0.0230 Jun 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jul 202430 Jun 2025(m)-0.02(m)(m)
1 Jul 202330 Jun 2024(m)-0.16(m)(m)
1 Jul 202230 Jun 2023(m)-0.10(m)(m)
1 Jul 202130 Jun 2022(m)-0.06(m)(m)
1 Jul 202030 Jun 2021(m)-0.07(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 100.92M* ■ Earnings -1.94M* — Profit margin -1.92%*

-36.86M-24.1%15.44M-16.4%67.73M-8.6%120.03M-0.9%30 Sept 2025: revenue 93.94M; earnings -21.68M; profit margin -23.08%30 Sept 202531 Dec 2025: revenue 102.24M; earnings -13.77M; profit margin -13.47%31 Dec 202531 Mar 2026: revenue 104.84M; earnings -11.80M; profit margin -11.26%31 Mar 202630 Jun 2026: revenue 100.92M*; earnings -1.94M*; profit margin -1.92%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2026-04-01 to 2026-06-30; USD.30 Jun 2026

30 Jun 2026 ■ Revenue 401.95M ■ Earnings -49.19M — Profit margin -12.24%

-110.12M-13.2%99.73M-8.6%309.58M-4.0%519.43M0.7%30 Jun 2023: revenue 447.61M; earnings -9.28M; profit margin -2.07%30 Jun 202330 Jun 2024: revenue 446.55M; earnings -15.54M; profit margin -3.48%30 Jun 202430 Jun 2025: revenue 458.50M; earnings -1.59M; profit margin -0.35%30 Jun 202530 Jun 2026: revenue 401.95M; earnings -49.19M; profit margin -12.24%30 Jun 2026

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$0.30(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$0.30High(m)Average(m)Low(m)2025-09-292026-09-29

Recent news

View more →

YouTube videos mentioning ARAY

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-12; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-49.19M
Profit margin
-12.24%
Return on assets · 12 month
-10.77%
Index membership
(m)
Employees
809.00
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
19.96M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
30.43%*
Total return · month
11.11%*
Total return · quarter
15.38%*
Total return · half year
-25.00%*
Total return · year to date
-63.41%*
Total return · 1 year
-81.60%*
Total return · 3 years
-88.97%*
Total return · 5 years
-92.44%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$401.95M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
354.61%*
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

ACCURAY INCORPORATED Overview

View more →

(m)

(m)

SEC CIK
1138723
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Country of operation
United States
Business address
1240 DEMING WAY, MADISON, Wisconsin, 53717, United States
Fiscal year end
0630
Phone
608-824-2800

Similar stocks

Stock NameCountryMarket CapPE Ratio
Glucotrack, Inc. (GCTK)United States$0.027B
PAVmed Inc. (PAVM)United States$0.031B-3.00
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
InspireMD, Inc. (NSPR)$0.033B
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
Modular Medical, Inc. (MODD)United States$0.018B-0.88
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
CERENOME, INC. (CNSY)United States$0.014B
Sintx Technologies, Inc. (SINT)United States$0.012B-1.10